Recommendations Developed for Evaluation of Patients With Alzheimer Disease

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 6, 2025 -- In a clinical practice guideline issued by the Alzheimer's Association and published online Dec. 23 in Alzheimer's & Dementia, recommendations are presented for the diagnostic evaluation of patients with Alzheimer disease (AD) or AD and related dementias (ADRD). The guideline is applicable to both specialist care and primary care of patients with AD/ADRD.

Alireza Atri, M.D., Ph.D., from Banner Sun Health Research Institute and Banner Alzheimer's Institute in Sun City, Arizona, and colleagues developed an evidence-based guideline to empower clinicians to implement a structured approach for assessing patients with symptoms that may represent clinical AD/ADRD. A total of 7,374 publications were reviewed, and of these, 133 met the inclusion criteria. Recommendations were developed in a patient-centered evaluation process.

The authors recommend that clinicians initiate a multitiered evaluation focused on the problem presented by a patient with self- or partner-reported cognitive, behavioral, or functional changes. Clinicians should use patient-centered communication to establish shared goals for the evaluation process and assess the patient's capacity to engage in the goal-setting process. A structured but personalized diagnostic evaluation of cognitive or behavioral symptoms is recommended using hierarchical tiers of assessments and tests tailored to the patient. During history taking, clinicians should obtain reliable information on changes in cognition, activities of daily living, mood and other neuropsychiatric symptoms, and sensory and motor function, as well as individualized risk factors for cognitive decline. Laboratory tests should also be multitiered and individualized to the patient's medical risks and profile.

"This first U.S. interdisciplinary national evaluation guideline, designed for broad clinical settings, provides a comprehensive foundation summarizing a high-quality and personalized process within which specific tests are slotted and can be updated as the field evolves," Atri said in a statement.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords